QserveÒ Group, a leading consulting group in medical device compliance, today announced the completion of the transition to new leadership for the company.
Willibrord Driessen founded Qserve in 1998 and built the company with locations in USA, Europe and China to a strong team of medical device consultants. Since 2014, three new shareholders joined the Board of Directors with the strong aim to continue in line with Willibrord’s global vision.
After a 3 years’ transition period of jointly growing the activities, competences and services of Qserve, Willibrord has now stepped down as a shareholder and Executive Director. With this step, he takes a bit more distance from the company’s daily operations, while at the same time still remaining active for Qserve to share his extensive experience as a Principal Consultant in client projects.
The Board of Qserve Group now continues with shareholders Jan van Lochem, Martin de Bruin and Gert Bos. They will continue to expand Qserve Group as a leading global medical device consulting group in Quality Systems, Regulatory compliance, Clinical Affairs & CRO services, and Training on all compliance aspects
The medical device sector is undergoing significant changes with fast moving technological innovations, increasing regulatory scrutiny in Europe, Americas and China and expanding global regulatory systems in many countries around the world. With the new EU Medical Device Regulation expected to be published still before the summer, the sector will further need to increase its compliance level and ensure sufficient clinical data will be brought in place. These developments further drive the need for high quality consultancy services to support continued regulatory compliance and bringing new innovations to global markets. Qserve will continue to play an important role to serve its clients, having all the needed and broad expertise- and professionals in-house.
Jan van Lochem, CEO of Qserve Group said: “I am grateful for the foundation Willibrord has created for a globally operating team of highly qualified professionals. He has had the vision to build a company that can serve manufacturers from our offices in USA, Europe and China to help bring safe medical devices to patients around the world. He has always been passionate about and felt responsible for our customers, our teams and their families. I am honored to be in the position to lead Qserve Group based on these same values in his spirit toward continued success, further growth and excellent customer service.”
Speaking about his stepping down from the Board, Willibrord Driessen stated: “With confidence and trust, I step down as shareholder and Executive Director, to give the new management of Qserve under the leadership of Jan together with Martin and Gert, the full opportunity to grow and maintain the brand Qserve for the up coming years. All three, are already highly respected professionals and senior managers for years working in the medical device sector. I have full trust in the Qserve Group that they continue and maintain to serve its clients with Quality and having “a Practical Approach” in mind
About Qserve Group
Qserve mission is to support all medical manufacturers with a practical approach, translating existing regulations to understandable requirements. We serve to guide manufacturers in gaining and maintaining compliance for their safe and qualitative devices in the most streamlined way possible.
Qserve’s global team combines their regulatory knowledge and experience in the medical device industry, sharing more than 500 years’ worth of combined expertise in the medical field. Having offices in EU, USA, and China provides the global footprint for global regulatory, clinical, and quality services.
Subscribe to the Qserve Newsletter and follow us on LinkedIn to stay up-to-date
on the latest regulatory and clinical news in the medical devices area.